New advances in Diabetic Retinopathy: A Narrative Review

¹The Liaquat University of Medical and Health Sciences, Pakistan

²Liaquat College of Medicine and Dentistry, Pakistan

*Corresponding Author: Tabish Ali Shalwani, The Liaquat University of Medical and Health Sciences, Pakistan; [email protected]  

Received Date: May 11, 2024

Publication Date: May 24, 2024

Citation: Shalwani TA, et al. (2024). New advances in Diabetic Retinopathy: A Narrative Review. Diab Res. 1(1):5.

Copyright: Shalwani TA, et al. © (2024). 

ABSTRACT

Retinal vasculitis brought on by the consequences of diabetes mellitus is known as diabetic retinopathy. Globally, the prevalence of diabetic retinopathy has skyrocketed, making it a primary cause of blindness and visual impairment in individuals over 20. There are a number of risk factors for diabetic retinopathy including duration of diabetes, poor metabolic control, puberty, gender, hypertension, high lipid levels, nephropathy, and surgery. Clinical practice recommendations include 1) treating hyperlipidemia, 2) controlling arterial hypertension to levels below 130/80 mm Hg, and 3) bringing blood sugar levels down to levels to normal (HbA1c = 7.0%). It is possible to reduce the prevalence and incidence of diabetes mellitus and, consequently, its consequences by weight loss, exercise, and healthy eating.

Keywords: Diabetic Retinopathy, Ophthalmological Findings, Pharmacotherapy, Diabetic Control, Metabolic Control